Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28501140

Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2017 Jul 1
First author
Hida T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Jul 1;390(10089):3-4. doi: 10.1016/S0140-6736(17)31074-7.
    note
    Source null
    related pmid
    28501139
    relationship
    Comment in
  2. citation
    J Thorac Dis. 2017 Aug;9(8):2242-2245. doi: 10.21037/jtd.2017.06.134.
    note
    Source null
    related pmid
    28932515
    relationship
    Comment in
  3. citation
    J Thorac Dis. 2017 Aug;9(8):2311-2314. doi: 10.21037/jtd.2017.07.76.
    note
    Source null
    related pmid
    28932533
    relationship
    Comment in
  4. citation
    J Thorac Dis. 2017 Sep;9(9):2812-2818. doi: 10.21037/jtd.2017.08.79.
    note
    Source null
    related pmid
    29221246
    relationship
    Comment in
  5. citation
    Ann Transl Med. 2017 Dec;5(23):460. doi: 10.21037/atm.2017.09.05.
    note
    Source null
    related pmid
    29285493
    relationship
    Comment in
  6. citation
    J Thorac Dis. 2018 Jan;10(1):106-108. doi: 10.21037/jtd.2017.12.76.
    note
    Source null
    related pmid
    29600033
    relationship
    Comment in
  7. citation
    J Thorac Dis. 2018 Jul;10(Suppl 18):S2130-S2132. doi: 10.21037/jtd.2018.06.45.
    note
    Source null
    related pmid
    30123541
    relationship
    Comment in
  8. citation
    J Thorac Dis. 2018 Jul;10(Suppl 18):S2138-S2143. doi: 10.21037/jtd.2018.06.142.
    note
    Source null
    related pmid
    30123543
    relationship
    Comment in

Authors and identifiers

  1. name
    Hida T
    type
    Author
  2. name
    Nokihara H
    type
    Author
  3. name
    Kondo M
    type
    Author
  4. name
    Kim YH
    type
    Author
  5. name
    Azuma K
    type
    Author
  6. name
    Seto T
    type
    Author
  7. name
    Takiguchi Y
    type
    Author
  8. name
    Nishio M
    type
    Author
  9. name
    Yoshioka H
    type
    Author
  10. name
    Imamura F
    type
    Author
  11. name
    Hotta K
    type
    Author
  12. name
    Watanabe S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hida T
    type
    Author
  2. name
    Nokihara H
    type
    Author
  3. name
    Kondo M
    type
    Author
  4. name
    Kim YH
    type
    Author
  5. name
    Azuma K
    type
    Author
  6. name
    Seto T
    type
    Author
  7. name
    Takiguchi Y
    type
    Author
  8. name
    Nishio M
    type
    Author
  9. name
    Yoshioka H
    type
    Author
  10. name
    Imamura F
    type
    Author
  11. name
    Hotta K
    type
    Author
  12. name
    Watanabe S
    type
    Author
bibliography ids
  1. nci-bib-4631b8f402f8292297ab04ef
book metadata
content sha256
62f11f47cf0573019cb8a3ce916597dca641164b18ec96a1ec5f277f47e60a58
document type
citation
dois
  1. 10.1016/S0140-6736(17)30565-2
electronic publication date
display
2017 May 10
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28501140
immutable id
pubmed:28501140@62f11f47cf0573019cb8a3ce916597dca641164b18ec96a1ec5f277f47e60a58
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10089
name
Lancet (London, England)
nlm unique id
2985213R
pages
29-39
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2017 Jul 1;390(10089):3-4. doi: 10.1016/S0140-6736(17)31074-7.
    note
    Source null
    related pmid
    28501139
    relationship
    Comment in
  2. citation
    J Thorac Dis. 2017 Aug;9(8):2242-2245. doi: 10.21037/jtd.2017.06.134.
    note
    Source null
    related pmid
    28932515
    relationship
    Comment in
  3. citation
    J Thorac Dis. 2017 Aug;9(8):2311-2314. doi: 10.21037/jtd.2017.07.76.
    note
    Source null
    related pmid
    28932533
    relationship
    Comment in
  4. citation
    J Thorac Dis. 2017 Sep;9(9):2812-2818. doi: 10.21037/jtd.2017.08.79.
    note
    Source null
    related pmid
    29221246
    relationship
    Comment in
  5. citation
    Ann Transl Med. 2017 Dec;5(23):460. doi: 10.21037/atm.2017.09.05.
    note
    Source null
    related pmid
    29285493
    relationship
    Comment in
  6. citation
    J Thorac Dis. 2018 Jan;10(1):106-108. doi: 10.21037/jtd.2017.12.76.
    note
    Source null
    related pmid
    29600033
    relationship
    Comment in
  7. citation
    J Thorac Dis. 2018 Jul;10(Suppl 18):S2130-S2132. doi: 10.21037/jtd.2018.06.45.
    note
    Source null
    related pmid
    30123541
    relationship
    Comment in
  8. citation
    J Thorac Dis. 2018 Jul;10(Suppl 18):S2138-S2143. doi: 10.21037/jtd.2018.06.142.
    note
    Source null
    related pmid
    30123543
    relationship
    Comment in
outcomes validated
false
pmid
28501140
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
474e72496891f28041d666882cf8c15571c8481440c4d27fbbefa4e744cb87b6
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Jul 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28501140/
title
Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.

Preserved source evidence · Not medical advice